bell
The current prices are delayed by 15 mins, login to check live prices.
Sanofi India Ltd share price logo

Sanofi India Ltd

(SANOFI)

₹7177.550.43%

as on 04:01PM, 19 Sep 2024

Overview
News
Financials
Q1 2024 Results
Technicals

Analyst Rating

based on 4 analysts

BUY

80.00%

Buy

0.00%

Hold

20.00%

Sell

Based on 4 analysts offering long term price targets for Sanofi India Ltd. An average target of ₹8176.25

Source: S&P Global Market Intelligence

Sanofi India Ltd Share analysis

Sanofi India Ltd price forecast by 4 analysts

Upside of14.40%

High

₹9345

Target

₹8176.25

Low

₹7560

Sanofi India Ltd target price ₹8176.25, a slight upside of 14.4% compared to current price of ₹7177.55. According to 4 analysts rating.

Source: S&P Global Market Intelligence

Performance

  • Day's Low

    Day's High

    ₹7,102.05
    ₹7,225.95
  • 52 Week's Low

    52 Week's High

    ₹5,892.8
    ₹10,524.95
1 Month Return+ 6.16 %
3 Month Return-0.61 %
1 Year Return+ 0.27 %
Previous Close₹7,146.90
Open₹7,150.00
Volume16.14K
Upper Circuit-
Lower Circuit-
Market Cap₹16,459.31Cr

Key Statistics

P/E Ratio31.09
PEG Ratio0.33
Market Cap₹16,459.31 Cr
P/B Ratio18.27
EPS262.13
Dividend Yield2.07
SectorPharmaceuticals
ROE52.65

Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
BUY₹16,459.31 Cr5.22%0.52₹602 Cr₹2,851 Cr
BUY₹90,184.74 Cr30.78%0.56₹3,168 Cr₹29,001 Cr
HOLD₹1,08,668.24 Cr70.73%0.64₹3,854 Cr₹19,547 Cr
BUY₹59,038.98 Cr36.49%0.53NANA
BUY₹47,286.31 Cr20%0.56₹589 Cr₹3,453 Cr

Company Information

Sanofi India Limited (formerly Aventis Pharma) is one of the leading multinational companies (MNCs) in the Indian Pharmaceutical Market. It produces medicines for diabetes, cardiology, thrombosis, epilepsy, allergies, infections, vitamins, central nervous system and antihistamines. Its top products - Lantus, Combiflam, Amaryl and Allegra - feature among the top 100 pharmaceutical brands in India. Sanofi India has 2 own manufacturing facilities in Goa and Ankleshwar in Gujarat and sells products through independent distributors, primarily in India. Sanofi and Hoechst GmbH are the major shareholders of Sanofi India Limited holding 60.4% of its paid-up share capital. In the past few decades, the company has gone through several transformations, launched numerous products and merged/acquired a joint venture and a subsidiary company. In 2020, Sanofi India closed the transaction of slump sale and transfer of its Ankleshwar manufacturing facility to Zentiva Private Limited. In 2021, Sanofi India sold its Nutraceuticals business on a going concern basis to Universal Nutriscience Private Limited for a consideration of ₹5,870 million.

Share Price: ₹7177.55 per share as on 19 Sep, 2024 04:01 PM
Market Capitalisation: ₹16,459.31Cr as of today
Revenue: ₹463.50Cr as on June 2024 (Q2 24)
Net Profit: ₹103.20Cr as on June 2024 (Q2 24)
Listing date: 06 Dec, 1994
Chairperson Name: Aditya Narayan
OrganisationSanofi India Ltd
Headquarters
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Sanofi India Ltd

  • Sanofi Settles Patent Dispute with Panacea Biotec - 17 Sep, 2024

    Sanofi Healthcare India has reached a settlement with Panacea Biotec regarding a patent infringement dispute over a hexavalent vaccine. Sanofi will not launch its Shan6 vaccine in India and will withdraw its patent oppositions against Panacea's vaccine.

  • Sanofi Settles Vaccine Patent Dispute in India - 16 Sep, 2024

    Sanofi has agreed not to launch its competing vaccine, Shan6, in India and will withdraw patent oppositions against Panacea Biotec's hexavalent vaccine, signaling a resolution in their dispute.

  • Sanofi India Reports Decline Amid Yearly Gains - 13 Sep, 2024

    Sanofi India shares fell nearly 1% despite a 35% year-to-date surge. Q1 FY25 net profit declined 16% YoY to Rs 103.2 crore, with revenue down 10% to Rs 463.5 crore.

  • Sanofi India Ltd Continues Upward Trend - 04 Sep, 2024

    Sanofi India Ltd has risen for the fifth consecutive session, trading at Rs 7265.05, up 1.86% today. The stock has gained 13.34% in the last month, despite a decline in the benchmark NIFTY. Its PE ratio stands at 33.42 based on TTM earnings.

  • Sanofi India Announces Management Change - 30 Aug, 2024

    Sanofi India Limited announced the cessation of Cyrus Aibara as Senior Director of Diabetes effective August 30, 2024. The company appreciates his contributions and has appointed Suresh Babu as his successor.

Insights on Sanofi India Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 10.41% to 11.00% in Jun 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 78.3% return, outperforming this stock by 78.0%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 60.40% of holdings in Jun 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 142.7% return, outperforming this stock by 151.4%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 6.11% to 5.81% in Jun 2024 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, SANOFI stock has moved down by -6.9%

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 11.67% to 11.59% in Jun 2024 quarter

Company Financials

Value in ₹ crore
DetailsQ'2 23Q'3 23Q'4 23Q'1 24Q'2 24
Revenue₹514.90Cr (-)₹714.60Cr (↑38.78%)₹693.90Cr (↓2.90%)₹510.80Cr (↓26.39%)₹463.50Cr (↓9.26%)
Net Income₹122.90Cr (-)₹151.90Cr (↑23.60%)₹137.70Cr (↓9.35%)₹136.60Cr (↓0.80%)₹103.20Cr (↓24.45%)
Net Profit Margin23.87% (-)21.26% (↓10.93%)19.84% (↓6.68%)26.74% (↑34.78%)22.27% (↓16.72%)
Value in ₹ crore
Details2020202120222023
Total Assets₹2,961.50Cr (-)₹3,105.60Cr (↑4.87%)₹2,112.50Cr (↓31.98%)₹1,752.50Cr (↓17.04%)
Total Liabilities₹842.50Cr (-)₹880.00Cr (↑4.45%)₹836.70Cr (↓4.92%)₹737.00Cr (↓11.92%)
Value in ₹ crore
Details20192020202120222023
Operating Cash Flow₹412.30Cr (-)₹611.10Cr (↑48.22%)₹558.80Cr (↓8.56%)₹398.70Cr (↓28.65%)₹230.80Cr (↓42.11%)

Index Inclusions

Nifty Smallcap 250

₹18,270.40

-1.11 (-205.4%)

Nifty 500

₹23,853.95

-0.19 (-44.7%)

Nifty MidSmallcap 400

₹20,684.65

-0.73 (-152.4%)

NIFTY PHARMA

₹22,930.15

-0.41 (-95.05%)

Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
60.4%
0.00
Foreign Institutions
5.81%
-4.84
Mutual Funds
11.59%
-0.68
Retail Investors
11%
5.61
Others
11.2%
-1.84

Key Indicators

Details20192020202120222023
Return On Equity %19.420.9426.7530.0552.65
Details20042023
Book Value Per Share (₹)189.4441.39
Details20042023
Earning Per Share (₹)65.45262.13

Sanofi India Ltd Valuation

Sanofi India Ltd in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

December 29, 2023

Today (31.09x)

September 18, 2024

Industry (58.50x)

September 18, 2024

Highest (42.25x)

June 12, 2024

LowHigh

Earnings and Dividends

  • Sanofi India Ltd Earnings Results

    Sanofi India Ltd’s net profit fell -16.03% since last year same period to ₹103.20Cr in the Q1 2024-2025. On a quarterly growth basis, Sanofi India Ltd has generated -24.45% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Sanofi India Ltd Dividends February,2024

    In the quarter ending December 2023, Sanofi India Ltd has declared dividend of ₹117 - translating a dividend yield of 7.61%.

    Read More about Dividends

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Sanofi India Ltd is currently in a Bullish trading position according to technical analysis indicators.

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Sanofi India Ltd shares.

Sanofi India Ltd (SANOFI) share price today is ₹7177.55

Sanofi India Ltd is listed on NSE

Sanofi India Ltd is listed on BSE

  • Today’s highest price of Sanofi India Ltd is ₹7225.95.
  • Today’s lowest price of Sanofi India Ltd is ₹7102.05.

PE Ratio of Sanofi India Ltd is 31.09

PE ratio = Sanofi India Ltd Market price per share / Sanofi India Ltd Earnings per share

Today’s traded volume of Sanofi India Ltd(SANOFI) is 16.14K.

Today’s market capitalisation of Sanofi India Ltd(SANOFI) is ₹16459.31Cr.

Sanofi India Ltd(SANOFIPrice
52 Week High
₹10524.95
52 Week Low
₹5892.8

Sanofi India Ltd(SANOFI) share price is ₹7177.55. It is down -31.80% from its 52 Week High price of ₹10524.95

Sanofi India Ltd(SANOFI) share price is ₹7177.55. It is up 21.80% from its 52 Week Low price of ₹5892.8

Sanofi India Ltd(SANOFIReturns
1 Day Returns
30.65%
1 Month Returns
6.16%
3 Month Returns
-0.61%
1 Year Returns
0.27%